MTX: METHOTREXATE
MTX is a Ligand Of Interest in 2OIP designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 2OIP_MTX_A_605 | 75% | 22% | 0.104 | 0.939 | 1.33 | 1.82 | 3 | 8 | 8 | 0 | 100% | 1 |
| 2OIP_MTX_B_609 | 71% | 23% | 0.113 | 0.935 | 1.34 | 1.7 | 3 | 7 | 11 | 0 | 100% | 1 |
| 2OIP_MTX_D_617 | 66% | 23% | 0.126 | 0.933 | 1.3 | 1.75 | 2 | 7 | 9 | 0 | 100% | 1 |
| 2OIP_MTX_E_621 | 45% | 26% | 0.151 | 0.881 | 1.24 | 1.66 | 2 | 7 | 12 | 0 | 100% | 1 |
| 2OIP_MTX_C_613 | 44% | 25% | 0.164 | 0.894 | 1.26 | 1.67 | 2 | 7 | 8 | 0 | 100% | 1 |
| 6PF7_MTX_B_604 | 89% | 25% | 0.08 | 0.964 | 1.01 | 1.89 | 1 | 14 | 1 | 0 | 100% | 1 |
| 3HJ3_MTX_B_609 | 87% | 13% | 0.073 | 0.951 | 1.92 | 1.94 | 10 | 10 | 5 | 0 | 100% | 1 |
| 6PFG_MTX_C_604 | 84% | 19% | 0.088 | 0.956 | 1.59 | 1.79 | 5 | 8 | 3 | 0 | 100% | 1 |
| 6PFF_MTX_A_604 | 82% | 17% | 0.094 | 0.955 | 1.6 | 1.9 | 5 | 11 | 4 | 0 | 100% | 1 |
| 6PFH_MTX_B_604 | 81% | 18% | 0.092 | 0.95 | 1.62 | 1.77 | 5 | 8 | 1 | 0 | 100% | 1 |
| 1RB3_MTX_A_161 | 100% | 6% | 0.02 | 0.996 | 1.81 | 3 | 11 | 27 | 3 | 0 | 100% | 1 |
| 7F3Y_MTX_A_702 | 99% | 52% | 0.043 | 0.987 | 0.58 | 1.11 | - | 3 | 0 | 0 | 100% | 1 |
| 9D6X_MTX_D_401 | 99% | 60% | 0.041 | 0.984 | 0.7 | 0.67 | 1 | - | 2 | 0 | 100% | 1 |
| 1RA3_MTX_A_161 | 97% | 10% | 0.048 | 0.972 | 1.64 | 2.56 | 8 | 24 | 3 | 0 | 100% | 1 |
| 1RG7_MTX_A_161 | 97% | 8% | 0.051 | 0.972 | 1.91 | 2.56 | 9 | 19 | 3 | 0 | 100% | 1 |